cmi_logo.png
[Latest] Global Human Insulin Market Size/Share Worth USD 70.68 Billion by 2030 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 20, 2023 12:30 ET | Custom Market Insights
Austin, TX, USA, July 20, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Human Insulin Market Size, Trends and Insights By Type (Modern Human Insulin,...
cmi_logo.png
[Latest] Global Cell Culture Media Market Size/Share Worth USD 11799 Million by 2032 at a 12.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 17, 2023 12:30 ET | Custom Market Insights
Austin, TX, USA, July 17, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell Culture Media Market for Regenerative Medicines Size, Trends and Insights...
cmi_logo.png
[Latest] Global Regenerative Medicine Market Size/Share Worth USD 174.72 Billion by 2032 at a 22.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 10, 2023 13:30 ET | Custom Market Insights
Austin, TX, USA, July 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Regenerative Medicine Market Size, Trends and Insights By Product (Serum-free...
MaximizeMarketResearch
Chronic Kidney Disease Market is expected to hit USD 93.91 Bn by 2029 at a CAGR of 5.2 percent – says Maximize Market Research        
May 12, 2023 04:27 ET | MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, May 12, 2023 (GLOBE NEWSWIRE) -- A global Healthcare research and business-consulting firm, Maximize Market Research, has published a market intelligence report on the “Chronic Kidney Disease...
researchdrivelogo.jpg
Global Respiratory Disease Testing Market Expected to Garner a Revenue of $20.1 Billion by 2027, despite COVID-19 Crisis | | Declared by Research Dive
September 14, 2022 09:02 ET | Research Dive
New York, USA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global respiratory disease testing market is anticipated to generate a revenue of $20.1...
TIP_link_300x300.jpg
Hospital Bed Market Size Worth $4,688.96 Million by 2028 at 5.7% CAGR Global Analysis by Type (Semi-Electric Beds, Electric Beds, Manual Beds)
September 01, 2022 05:48 ET | The Insight Partners
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Hospital Bed Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
Straits Research Pvt Ltd
Clinical Nutrition Market Size is projected to reach USD 60.35 billion by 2030, growing at a CAGR of 6.3%: Straits Research
July 21, 2022 14:50 ET | Straits Research
New York, United States, July 21, 2022 (GLOBE NEWSWIRE) -- A clinical nutrition product improves a patient's health. Necessary supplements such as minerals, vitamins, and other nutrients aid in the...
TIP_link_300x300.jpg
$179.34 Million by 2028, OPEP (Oscillating Positive Expiratory Pressure) Devices Market, 5.2% CAGR Lead by Mouthpiece PEP Devices - Exclusive Research Report by The Insight Partners
May 10, 2022 04:13 ET | The Insight Partners
New York, May 10, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 – COVID-19 Impact...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
September 16, 2021 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
AzurRx_Logo_CMYK.jpg
AzurRx BioPharma to Present at the Emerging Growth Conference (May 12)
May 11, 2021 08:30 ET | AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of...